The retinoblastoma gene family and its role in proliferation, differentiation and development

Histology and Histopathology

Volumn 11, Issue 4, 1996, Pages 1029-1034

  De Luca, A ^a   Esposito, V ^a   Baldi, A ^a   Giordano, A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

cell cycle; development; retinoblastoma gene family; tumor suppressor gene

Indexed keywords

RETINOBLASTOMA PROTEIN;

CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; HUMAN; HUMAN CELL; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; GENES, RETINOBLASTOMA; GROWTH; HUMANS; MODELS, BIOLOGICAL; MULTIGENE FAMILY; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS;

EID: 0029856197     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Saldi A., De Luca A., Claudio P.P., Baldi F., Giordano G.G., Tommasino M., Paggi M.G. and Giordano A. (1995). The Rb2/p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. J. Cell. Biochem. 59, 1-7.
2. Baldi A., Esposito V., De Luca A., Howard C.M., Mazzarella G., Baldi F., Caputi M. and Giordano A. (1996a). Differential expression of the retinoblastoma gene family members pRb/p105, p107, and pRB2/p130 in lung cancer. Clin. Cancer Res. 2, 1239-1245.
3. Baldi A., Boccia V., Claudio P.P., De Luca A. and Giordano, A. (1996) Genomic structure of the human retinoblastoma-related Rb2/p130 gene. Proc. Natl. Sci. USA 93, 4629-4632.
4. Beijersbergen R.L., Carlee L., Kerkhoven R.M, and Bernards R. (1993). Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9, 1340-1353.
5. Bernards R., Shackleford G.M., Gerber M., Horowitz J.M , Friend S. H., Schartl M., Bogenmann E., Rapaport J.M., McGee T., Dryja T. P. and Weinberg R.A. (1989). Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc. Natl. Sci. USA 86, 6474-6478.
6. Biggs P.J., Wooster R., Ford D., Chapman P., Mangion J., Quirk Y., Easton D.F., Burn J. and Stratton M.R. (1995). Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13; evidence for its role as a tumour suppressor gene. Nat. Genet. 11, 441-443.
7. Bignon Y.J., ChenY., Chang C.Y., Riley D.J., Windle J.J., Mellon P.L. and Lee W.H. (1993). Expression of a retinoblastoma transgene results in dwarf mice. Genes Dev. 7, 1654-1662.
8. Bookstein R., Rio P., Madreperla S.A., Hong F., Allred C., Grizzle W.E. and Lee. W.H. (1990a). Promoter deletion and loss of retinoblastoma gene in human prostate carcinoma. Proc. Natl. Acad. Sci. USA 87, 7762-7766.
9. Bookstein R., Shew J.Y., Chen P.L., Scully P, and Lee W.H. (1990b). Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247, 712-715.
10. Chellapan S.P. (1994). The E2F transcription factor: role in cell cycle regulation and differentiation. Mol. Cell. Diff. 2, 201-220.
11. Chellapan S.P., Hiebert S., Mudryj M., Horowitz J.M. and Nevins J.R. (1991). The E2F transcription factor is a cellular target for the RB protein. Cell 65, 1053-1061.
12. Chen P.L., Scully P., Shew J.Y., Wang J.J. and Lee W.H. (1989). Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 1193-1198.
13. Clarke A.R., Mandag A.R., Roon M.V., Lugt N.M., Valk M.V., Hooper M.L., Berns A, and Riele H.T. (1992). Requirement of a functional Rb-1 gene in murine development. Nature 359, 328-330.
14. Claudio P.P., Howard C.M., Baldi A., De Luca A., Fu Y., Condorelli G., Sun Y., Colburn N., Calabretta B. and Giordano A. (1994). pRb2/p130 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res. 54, 5556-5560.
15. Claudio P.P., De Luca A., Howard C.M., Baldi A., Firpo E.J., Koff A., Paggi M.G. and Giordano A. (1996). Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res. 56, 2003-2008.
16. Cobrinik D., Whyte P., Peeper D.S., Jacks T. and Weinberg R.A. (1993). Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7, 2392-2404.
17. Condorelli G., Testa U., Valtieri M., De Luca A., Barberi T., Vitelli L., Montesoro E., Campisi S., Giordano A. and Peschle C. (1995). Developmental regulation of Rb in normal adult hematopoiesis: peak expression and functional role in advanced erythroid differentiation. Proc. Natl. Acad. Sci. USA 92, 4808-4812.
18. Coppola J.A., Lewis A. and Cole M.D. (1990). Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene 5,1731-1733.
19. De Caprio J.A., Ludlow J.W., Figge J., Shew J.Y., Huang C.M., Lee W.H., Marsilio E., Paucha E. and Livingston D.M. (1988). SV40 Large Tumor Antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54, 275-283.
20. De Caprio J.A., Furukawa Y., Ajchenbaum F., Griffin J.D. and Livingston D.M. (1992). The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl. Acad. Sci. USA 89, 1795-1798.
21. De Luca A., Baldi A., Claudio P.P., Howard C.M., Campisi S., Giordano A. and Condorelli G. (1995). The retinoblastoma gene and its role in cancer and differentiation. Front. Endocrinol. 14, 197-206.
22. Dowdy S.F., Hinds P.W., Louie K., Reed S.I., Arnold A. and Weinberg R.A. (1993). Physical interaction of the retinoblastoma protein with human D-cyclins. Cell 73, 499-511.
23. Dulic V., Lees E. and Reed S.I. (1992). Association of human cyclin E with a periodic G1-S phase protein of kinase. Science 257, 1958-1961.
24. Dyson N., Howley P.M., Muenger K. and Harlow E. (1989). The human Papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-937.
25. Ewen M.E., Xing Y., Lawrence J.B. and Livingston D.M. (1991). Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66, 1155-1164.
26. Ewen M.E., Sluss H.K., Sherr C.J., Matsushime H., Kato J.Y. and Livingston D.M. (1993). Functional interactions of the retinoblastoma protein with human D-cyclins. Cell 73, 487-497.
27. Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M. and Dryja T.P. (1986). A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643-646.
28. Fung Y.K., Murphree A.L., T'Ang A., Qian J., Hinrichs S.H. and Benedict W.F. (1987). Structural evidence for the authenticity of the human retinoblastoma gene. Science 236, 1657-1661.
29. Goodrich D.W., Wang N.P., Qian Y.W., Lee E.Y. and Lee W.H. (1991). The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67, 293-302
30. Grana X., De Luca A., Sang N., Fu Y., Claudio P.P., Rosenblatt J., Morgan D.O. and Giordano A. (1994). PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. USA. 91, 3834-3838.
31. Gu. W., Schneider J.W., Condorelli G., Kaushal S., Mahdavi V. and Nadal-Ginard B. (1993). Interaction of mitogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72, 309-324.
32. Hamel P.A., Phillips R.A., Muncaster M. and Gallie B.L. (1993). Speculations on the roles of Rb1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J. 7, 846-854.
33. Hannon G.J., Demetrick D. and Beach D. (1993). Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7, 2378-2391.
34. Hiebert S.W., Chellapan S.P., Horowitz J.M. and Nevins J.R. (1992). The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6, 177-185.
35. Hijmans E.M., Voorhoeve P.M., Beijersbergen R.L., Van'T Veer L.J. and Bernards R. (1995). E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15, 3082-3089.
36. Hollingsworth R.E., Hensey C.E. and Lee W-H. (1993). Retinoblastoma protein and the cell cycle. Curr. Opin. Genet. Dev. 3, 55-62.
37. Horowitz J.M., Yandell D.W., Park S.H., Canning S., Whyte P., Buchkovich K., Harlow E., Weinberg R.A. and Dryja T.P. (1989). Point mutational inactivation of the retinoblastoma antioncogene. Science, 243: 937-940, 1989.
38. Horowitz J.M., Park S.H., Bogenmann E., Cheng J.C., Yandell D.W., Kaye F.J., Minna J.D., Dryja T.P. and Weinberg R.A. (1990). Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA 87, 2775-2790.
39. Huang H.J., Yee J.K., Shew J.Y. and Chen P.L (1988). Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242, 1563-1566.
40. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A. and Weinberg R.A. (1992). Effects of an Rb mutation in the mouse. Nature 395, 295-300.
41. Jiang H., Lin J., Young S., Goldstein N.I., Waxman S., Davila V., Chellapan S.P. and Fisher P.B. (1995). Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate. Oncogene 11, 1179-1189.
42. Kaye F.J., Kratzke R.A., Gerster J.L and Horowitz J.M. (1990). A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc. Natl. Acad. Sci. USA 87, 6922-6926.
43. Kato J., Matsushime H., Hiebert S.W., Ewen M.E. and Sherr C.J. (1993). Direct binding of cyclin-D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7, 331-342.
44. Knudson A.G. (1971). Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820-823.
45. Knudson A.G. (1984). Retinoblastoma: clues to human oncogenesis. Science 228, 501-503.
46. Koff A., Giordano A., Desai D., Yamashita K., Harper J.W., Elledge S., Nishimoto T., Morgan D.O., Franza B.R. and Roberts J.M. (1992). Formation and activation of a cyclinE-cdk2 complex during the G1 phase of the human cell cycle. Science 257, 1689-1694.
47. Kranenburg O., van der Eb A.J. and Zantema A. (1995). Cyclin-dependent kinases and pRb regulators of the proliferation-differentiation switch. FEBS Lett. 367, 103-106.
48. Lee W.H., Bookstein R., Hong F., Young L.J., Shew J.Y. and Lee E.Y. (1987). Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235, 1394-1399.
49. Lee E.Y., Chang C.Y., Hu N., Wang Y.C., Lai C.C., Herrup K., Lee W.H. and Bradley A. (1992). Mice deficient for RB are nonviable and show defects in neurogenesis and hematopoiesis. Nature 359, 288-294.
50. Li Y., Graham C., Lacy S., Duncan A.M. and Whyte P. (1993). The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclin A and E. Genes Dev. 7, 2366-2377.
51. Mayol X., Grana X., Baldi A., Sang N., Hu Q. and Giordano A. (1993). Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8, 2561-2566.
52. Moran E. (1993). DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3, 63-70.
53. Nevins J.R. (1992). A link between the Rb tumor suppressor protein and viral oncoprotein. Science 258, 424-429.
54. Fertile P., Baldi A., De Luca A., Bagella L., Virgilio L., Pisano M.M. and Giordano A. (1995). Molecular cloning, expression and developmental characterization of the murine retinoblastoma-related gene Rb2/p130. Cell Growth Differ. 6, 1659-1664.
55. Richon V.M., Rifkind R.A. and Marks P.A. (1992). Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Cell Growth Differ. 3, 413-420.
56. Sang N., Baldi A. and Giordano A. (1995). The roles of tumor suppressors pRb and p53 in cell proliferation and cancer. Mol. Cell. Differ. 3, 1-29.
57. Shirodkar S., Ewen M., DeCaprio J.A., Morgan J., Livingston D.M. and Chitteden T. (1992). The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 66, 157-166.
58. Slack R.S., Hamel P.A., Bladon T.S., Gill R.M. and McBurney M.W. (1993). Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. Oncogene 8, 1585-1591.
59. Vairo G., Livingston D.M., Ginsberg D. (1995). Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9, 869-881.
60. Weinberg R.A. (1991). Tumor suppressor genes. Science 254, 1138-1146.
61. Whyte P., Buckovich K.J., Horowitz J.M., Friend S.H., Raybuck M., Weinberg R.A. and Harlow E. (1988). Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334, 124-127.
62. Yeung R.S., Bell D.W., Testa J.R., Mayol X., Baldi A., Grana X., Klinga-levan K., Knudson A.G. and Giordano A. (1993).The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene 8, 3465-3468.
63. Zhou Y., Li J., Xu K., Hu S.X., Benedict W. and Xu H.J. (1991). Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells. Cancer Res. 51, 6481-6484.
64. Zhu L., Van den Heuvel S., Helin K., Fattaey A., Ewen M., Livingston D.M., Dyson N. and Harlow E. (1993). Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7, 1111-1125.
65. Zhu L., Enders G., Lees J.A.; Beijersbergen R.L., Bernards R. and Harlow E. (1995). The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14, 1904-1913.